JWCA has advised APELLIS on capital market transactions with $943 MILLION in transaction Value

July 2022: JWCA advises Apellis Pharmaceuticals on the equitization of an additional $98.1mm of its convertible notes

July 2021: JWCA advises Apellis Pharmaceuticals on the equitization of an additional $201mm of its convertible notes

January 2021: JWCA advises Apellis Pharmaceuticals on the equitization of its convertible notes

May 2020: JWCA helps Apellis raise $300 million by designing a novel structure to re-open its convertible bond and capped call

September 2019: JWCA advises Apellis on its upsized $220 million debut convertible bond issuance and capped call